TCW Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-48,260
Closed -$2.54M 639
2016
Q4
$2.54M Sell
48,260
-17,450
-27% -$845K 0.02% 311
2016
Q3
$2.93M Sell
65,710
-4,062
-6% -$176K 0.02% 249
2016
Q2
$2.66M Sell
69,772
-25,466
-27% -$1.12M 0.02% 270
2016
Q1
$3.92M Buy
95,238
+25,601
+37% +$1.06M 0.03% 211
2015
Q4
$3.38M Buy
69,637
+17,963
+35% +$799K 0.02% 253
2015
Q3
$2.07M Buy
+51,674
New +$2.26M 0.01% 343

Other funds holding SYNH

TCW Group's SYNH Position: Q1 2017 in Review

TCW Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2017, closing a stake of 48,260 shares — an estimated $2.54M sold.

TCW Group first reported a position in SYNH in Q3 2015 and held it in 6 quarters. The position peaked at $3.92M in Q1 2016. 232 funds tracked by Wall St. Rank hold SYNH as of Q1 2017.

  • TCW Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2017 after selling out during the quarter.
  • TCW Group sold 48,260 Syneos Health, Inc. Class A Common Stock shares in Q1 2017, an estimated $2.54M.
  • TCW Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2015 and held it in 6 quarters.
  • TCW Group's Syneos Health, Inc. Class A Common Stock position peaked at $3.92M in Q1 2016.
  • 232 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2017.

Based on TCW Group's 13F filing for Q1 2017, filed 12 May 2017.